![Solventum Corporation](/common/images/company/NY_SOLV.png)
The current SOLV market cap is 9.43B. The company's latest EPS is USD 4.0067 and P/E is 13.63.
Quarter End | Mar 2024 |
---|---|
USD ($) | |
Total Revenue | 2.02B |
Operating Income | 381M |
Net Income | 237M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 8.24B |
Operating Income | 1.48B |
Net Income | 692M |
Quarter End | Mar 2024 |
---|---|
USD ($) | |
Total Assets | 14.71B |
Total Liabilities | 10.86B |
Total Equity | 3.85B |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 14.38B |
Total Liabilities | 10.97B |
Total Equity | 3.41B |
Market Cap | 9.43B |
Price to Earnings Ratio | 13.63 |
Price to Sales Ratio | 1.14 |
Price to Cash Ratio | 15.72 |
Price to Book Ratio | 2.77 |
Dividend Yield | - |
Shares Outstanding | 172.71M |
Average Volume (1 week) | 1.75M |
Average Volume (1 Month) | 1.92M |
52 Week Change | -21.04% |
52 Week High | 72.40 |
52 Week Low | 47.16 |
Spread (Intraday) | 2.12 (3.75%) |
Company Name | Solventum Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.solventum.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.